Ravenna, Italy

Edmondo Ferretti




Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Edmondo Ferretti

Introduction

Edmondo Ferretti is a notable inventor based in Ravenna, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of proteasome inhibitors. With a total of four patents to his name, Ferretti's work has the potential to impact the treatment of various diseases, including cancer.

Latest Patents

Ferretti's latest patents focus on proteasome inhibitors and methods of using them. These inventions provide boronic acid compounds and boronic esters that can modulate apoptosis by inhibiting proteasome activity. The compounds and compositions developed by Ferretti can be utilized in methods for inducing apoptosis and treating diseases associated with proteasome activity.

Career Highlights

Throughout his career, Edmondo Ferretti has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Cephalon, Inc. and Millennium Pharmaceuticals Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Ferretti has collaborated with several professionals in his field, including Raffaella Bernardini and Alberto Bernareggi. These collaborations have likely enhanced his research and development efforts, leading to the successful creation of his patented inventions.

Conclusion

Edmondo Ferretti's innovative work in the field of proteasome inhibitors showcases his dedication to advancing medical science. His contributions have the potential to lead to significant advancements in the treatment of diseases such as cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…